Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neural cues differentially modulate colorectal cancer cell behavior depending on patients' genomic background.

iScience·2026
Same author

The Rising Burden of Early-Onset Cancer: Challenges and Opportunities.

Cancer discovery·2026
Same author

WEE1 kinase inhibition to overcome acquired resistance to targeted therapies in colorectal cancer.

EMBO molecular medicine·2026
Same author

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Cancer discovery·2026
Same author

Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

Cancer discovery·2026
Same author

Mapping intratumor heterogeneity across layers for advancing immunotherapy.

Cell·2026
Same journal

Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

Cancer cell·2026
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.7K

Liquid Biopsies, What We Do Not Know (Yet).

Alberto Bardelli1, Klaus Pantel2

  • 1University of Torino, Department of Oncology, SP 142, Km 3.95, 10060 Candiolo, Torino, Italy; Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Torino, Italy.

Cancer Cell
|February 16, 2017
PubMed
Summary
This summary is machine-generated.

Liquid biopsies analyze cell-free DNA and circulating tumor cells in blood, offering a dynamic view of cancer evolution beyond tissue samples. This approach shows promise for early detection and monitoring treatment resistance in metastatic tumors.

More Related Videos

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

3.3K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.4K

Related Experiment Videos

Last Updated: Mar 7, 2026

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.7K
Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses
14:54

Biobanking of Human Aqueous and Vitreous Liquid Biopsies for Molecular Analyses

Published on: September 11, 2023

3.3K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Metastatic tumors exhibit molecular heterogeneity and genomic evolution, which are inadequately represented by traditional tissue biopsies.
  • Blood-based analyses, including cell-free DNA and circulating tumor cells, offer a non-invasive alternative for capturing tumor dynamics.

Purpose of the Study:

  • To review the current state and future directions of liquid biopsy research in oncology.
  • To highlight the potential of liquid biopsies for early cancer detection and monitoring minimal residual disease.
  • To address key challenges and open questions in the rapidly advancing field of liquid biopsies.

Main Methods:

  • Review of current literature on liquid biopsy technologies and applications.
  • Analysis of studies investigating cell-free DNA and circulating tumor cells for cancer profiling.
  • Discussion of clinical utility in monitoring disease response and drug resistance.

Main Results:

  • Liquid biopsies provide a dynamic molecular profile of tumors, overcoming limitations of static tissue specimens.
  • Current applications include monitoring treatment response and tracking the emergence of drug resistance.
  • Emerging applications focus on early cancer detection and surveillance for minimal residual disease.

Conclusions:

  • Liquid biopsies represent a paradigm shift in cancer management, leveraging blood for comprehensive molecular insights.
  • Further research is needed to fully realize the potential of liquid biopsies for early detection and MRD monitoring.
  • Addressing open questions is crucial for the widespread clinical adoption of liquid biopsy technologies.